Sort
40,608 grants matching “prostate cancer”
Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy
$687,250Nagavarakishore Pillarsetty · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
THE FUNCTION OF NEUROENDOCRINE CELLS IN PROSTATE CANCER
$687,156University Of California, Los Angeles · · FY2011 · Department of Defense
Hypothermic Storage and Cryopreservation of Corneas
$687,156J M Baust · Cell Preservation Services, Inc. · R44 · FY2008 · EY
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
$687,002Shalendar Bhasin · Brigham And Women'S Hospital · R01 · FY2017 · NR
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
$687,002Shalendar Bhasin · Brigham And Women'S Hospital · R01 · FY2016 · NR
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
$687,002Shalendar Bhasin · Brigham And Women'S Hospital · R01 · FY2018 · NR
Development/Clinical Validation Markers for Prostate Ca
$686,983Alan W Partin · Johns Hopkins University · U01 · FY2006 · CA
Role of Novel Cytokine Secretoglobin (SCGB) 3A2 in Lung
$686,816Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
$686,760Michael A Diefenbach · Feinstein Institute For Medical Research · R01 · FY2019 · CA
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
$686,710Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Acylcarnitine Metabolism in Ovarian Cancer Chemoresistance
$686,654Katherine Marie Aird · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Pilot study of an implantable microdevice to test multiple drug responses in prostate cancer patients
$686,566Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2021 · CA
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
$686,385David Basanta Gutierrez · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2016 · CA
Chemoprevention of Prostate Cancer via Estrogen Receptor B Agonists
$686,259Michael Pawlita · Iit Research Institute · N01 · FY2013 · CA
Leadership, Planning, and Evaluation
$686,254Stanton L Gerson · Case Western Reserve University · P30 · FY2022 · CA
1/1 Urinary Stone Disease Washington University Research Network
$686,250Hing Hung Henry Lai · Washington University · U01 · FY2016 · DK
Growth Factors and Prostate Cancer Risk
$686,097Brigham And Women'S Hospital · R01 · FY2002 · CA
IMAGING PROSTATE CANCER (PCA) PHENOTYPE EVOLUTION
$685,875Sloan-Kettering Institute For Cancer Research · · FY2013 · Department of Defense
Elucidation of cancer pathways and druggable targets using mouse models.
$685,776Cory Abate-Shen · Columbia University Health Sciences · U01 · FY2013 · CA
Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors
$685,764Alexi A Wright · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$685,757Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation
$685,730James Peter Basilion · Case Western Reserve University · R01 · FY2019 · EB
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI
$685,657Daniel B Vigneron · University Of California, San Francisco · R01 · FY2014 · EB
ATLANTA REGIONAL COMMUNITY CLINICAL ONCOLOGY PROGRAM
$685,649St. Joseph'S Hospital · U10 · FY2001 · CA
Iowa Oncology Research Association
$685,544Robert J. Behrens · Iowa Oncology Research Association · U10 · FY2010 · CA